過去3か月間に、7人のアナリストがIntellia Therapeutics(NASDAQ:NTLA)の格付けを発表し、強気から弱気までさまざまな視点を提供しています。
以下の表は、最近の評価をまとめた...
ログインすると全部閲覧できます。
ログイン
In the last three months, 7 analysts have published ratings on Intellia Therapeutics (NASDAQ:NTLA), offering a diverse range of perspectives from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
Bullish | Somewhat Bullish | Indifferent | Somewhat Bearish | Bearish | |
---|---|---|---|---|---|
Total Ratings | 2 | 5 | 0 | 0 | 0 |
Last 30D | 0 | 1 | 0 | 0 | 0 |
1M Ago | 0 | 1 | 0 | 0 | 0 |
2M Ago | 2 | 2 | 0 | 0 | 0 |
3M Ago | 0 | 1 | 0 | 0 | 0 |
Analysts have recently evaluated Intellia Therapeutics and provided 12-month price targets. The average target is $71.0, accompanied by a high estimate of $120.00 and a low estimate of $54.00. A 2.35% drop is evident in the current average compared to the previous average price target of $72.71.
A clear picture of Intellia Therapeutics...
過去3か月間に、7人のアナリストがIntellia Therapeutics(NASDAQ:NTLA)の格付けを発表し、強気から弱気までさまざまな視点を提供しています。
以下の表は、最近の評価をまとめた...
ブラウザの共有ボタンを使って、このページを友人と共有することができます。